Harvard doctors showed in 1992 that through-the-needle ablation could relieve excruciating pain from benign bone tumors.

FORBES: Magazine Article

In essence, the drug is slowing down cancer by altering its environment in way that makes it difficult for bone tumors to take hold.

FORBES: Amgen Exec: "Clearly Superior" Prostate Cancer Drug Will Be Huge

Ablation is approved for inoperable liver tumors and painful bone tumors, and doctors are also testing it on kidney tumors, lung tumors and even breast cancers.

FORBES: Tumor Zappers

The new therapy may prove useful to breast cancer or prostate cancer sufferers whose tumors have spread to the bone.

FORBES: Biotech Behemoth

It is more than a year away from getting approval to treat pain from bone cancer lesions and is targeting prostate, breast and brain tumors.

FORBES: Magazine Article

In a result eagerly awaited by Wall Street, drug developer Seattle Genetics announced that its experimental cancer medicine shrank tumors in 75% of patients with Hodgkin lymphoma that had relapsed despite rounds of chemotherapy and bone marrow transplants.

FORBES: Seattle Genetics Scores Win For Smart-Bomb Cancer Drugs